Pharmacy

The Pharmacy Department (Department of Pharmacy) of the Inner Mongolia Autonomous Region Cancer Hospital (Peking University Cancer Hospital Inner Mongolia Hospital) adheres to the motto of "Advocating honesty and goodness, pursuing innovation based on the foundation" and the purpose of serving doctors and patients wholeheartedly. It closely integrates the characteristics of the hospital and clinical needs, actively develops and innovates, and strives to transform the pharmaceutical work model. It has now become a comprehensive department integrating drug supply and deployment, clinical pharmacy services, adverse drug reaction monitoring, rational drug use consultation, drug clinical trial management, scientific research, and teaching.

The Department of Pharmacy currently has seven departments: clinical pharmacy group, inpatient pharmacy, central drug library, intravenous drug centralized preparation center, outpatient pharmacy, and drug clinical trial agency office.

There are currently 49 pharmaceutical technicians, 9 nursing staff and 3 other staff.

Pharmacy professional and technical personnel include 6 chief pharmacists, 10 deputy chief pharmacists, 14 chief pharmacists (middle), and 19 pharmacists.

Among them, 19 are master students, 15 are full-time undergraduates, and 33 have obtained national licensed pharmacist qualifications.

The Department of Pharmacy has complete rules and regulations, complete emergency plans, and conducts department quality assessments every month to assess the work quality and safety of each group.

The Office of Drug Clinical Trial Institutions passed the institutional qualification accreditation of the National Medical Products Administration on March 12, 2019.

Recognized majors: oncology, respiratory medicine, neurology, cardiovascular medicine, interventional radiation, and radiotherapy.

The first institutional registration was completed on October 22, 2020. The registered majors are oncology, respiratory medicine, cardiovascular medicine, and radiotherapy.

At the same time, our hospital took the lead in carrying out clinical phase I clinical drug trials in Inner Mongolia, mainly conducting bioequivalence and safety evaluation tests of generic drugs.

Undertake 1 generic drug consistency evaluation test;

There are 14 Phase III drug clinical trials, 7 of which are under development.

Passed two State Food and Drug Administration inspections of clinical trial sites.

The clinical pharmacy group mainly conducts special inspections of clinical rational use of antibacterial drugs, reviews of clinical applications of anti-tumor drugs, monitoring of adverse drug reactions, reviews of prescription orders for auxiliary drugs, and dynamic monitoring of various pharmaceutical management indicators in the hospital and various clinical departments.

There are currently 7 specialist clinical pharmacists who have received standardized training from the Ministry of Health, mainly involving four majors: antibacterial drugs, anti-tumor drugs, enteral and parenteral nutritional support, and pain.

The intravenous drug centralized dispensing center was put into operation in July 2015. It mainly conducts centralized dispensing of chemotherapy drugs and parenteral nutrition drugs.

Each pharmacy is responsible for the daily dispensing of medicines for outpatients and inpatients, as well as the collection, storage, distribution, and delivery of medicines for outpatients and inpatients.

The drug warehouse is responsible for the procurement, warehousing, storage, and distribution of medicines.

Ensure the use of medicines throughout the hospital.

The Clinical Pharmacy Teaching and Research Office was established, which is composed of the director of the teaching and research office, the secretary of the teaching and research office, and teaching teachers. They are responsible for teaching internships and elective courses to graduates of the clinical pharmacy major of the School of Pharmacy of Inner Mongolia Medical University.

In April 2023, it was approved as the “China Anti-Cancer Association Cancer Prevention and Treatment Science Education Base”.

By the end of 2023, the Department of Pharmacy will have 30 ongoing research projects.

Among them, there are 2 Inner Mongolia Natural Science and Technology Projects, 8 Inner Mongolia Medical University Projects, and 1 Autonomous Region Health Science and Technology Plan;

1 project from the Science and Technology Department of Inner Mongolia Autonomous Region;

2 public hospital scientific research joint fund science and technology projects;

2 National Health Commission Hospital Management Research Institute projects.

In the past five years, he has published nearly 70 papers, including 5 in SCI and 14 in core journals.

(Information updated as of December 31, 2023)